Viewing nowEuroCal Tablets (Osobon Substance)
Ossopan Substance 830mg
Tablet · OTC medication
Austin Pharma Co., Ltd.

MFDS item code 200002412 · Notified 2000.12.28
Promotes osteoporosis and fracture healing, improves calcium and phosphorus supply in pregnant and breastfeeding women
To promote osteoporosis or fracture healing, the supply of calcium and phosphorus is necessary. Additionally, during pregnancy and breastfeeding, adequate intake of calcium and phosphorus is crucial for the health of the mother and fetus or newborn. In both cases, it helps maintain bone health and growth, strengthening the skeleton and supporting normal physiological functions.
Osteoporosis: As an ossopan substance, the adult dose is 1660∼3320 mg once, twice a day. Other indications: As this medication, the adult dose is 830∼1660 mg once a day. Take before meals with a beverage.
This medication should not be taken by patients with hypercalcemia or sarcoidosis, or by those with kidney disease. Patients with a history of kidney stones or severely impaired kidney function should also refrain from using this medication. Individuals with allergies to the ingredients in this medication or infants under 12 months old should avoid it. While taking this medication, it is advisable not to concurrently use tetracycline antibiotics, phosphates, calcium salts, or antacids, and to space them at least 4 hours apart. Teas containing tannins, such as green tea or black tea, should be avoided before and after taking this medication. Patients who are currently receiving treatment, have mobility issues, or have heart or circulatory diseases, kidney problems, or a tendency to develop kidney stones should consult with their doctor or pharmacist before taking this medication. Caution is also necessary for those taking high doses of vitamin D or certain diuretics, sodium fluoride, aldosterone antagonists, etc. If symptoms such as constipation, hypotension, facial flushing, irregular heartbeat, nausea, vomiting, or skin rashes occur during use, stop taking the medication immediately and consult healthcare professionals. This medication must be strictly adhered to in terms of dosage and administration, especially in children, where supervision by a guardian is required. If symptoms do not improve or worsen after 1 month of taking the medication, consult healthcare professionals. Store this medication out of reach of children, away from direct sunlight, and in a dry, cool place. Additionally, it should be avoided to transfer the medication to another container, as this could lead to quality degradation or misuse risks. This medication contains specific dyes, so patients with allergies or hypersensitivity to these components should use it cautiously.
Not everyone experiences these, and they can vary from person to person.
This medication is susceptible to the effects of air and moisture, so it must be stored in a tightly sealed container. It is best to maintain the storage temperature between 1 degree and 30 degrees Celsius.
Light yellowish-brown oval film-coated tablet
30 tablets/bottle, 120 tablets/bottle, 240 tablets/bottle [120 tablets/bottle × 2], 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.